FDA Oversight of the Tissue Bank Industry

DSpace/Manakin Repository

FDA Oversight of the Tissue Bank Industry

Show simple item record

dc.contributor.advisor Hutt, Peter Barton en_US
dc.contributor.author Wang, Mary H. en_US
dc.date.accessioned 2012-06-07T20:45:45Z
dc.date.issued 2002 en_US
dc.identifier.citation FDA Oversight of the Tissue Bank Industry (2002 Third Year Paper) en
dc.identifier.uri http://nrs.harvard.edu/urn-3:HUL.InstRepos:8852205
dc.description.abstract Until recently, FDA oversight of the human tissue industry has been spotty, even nonexistent. However, industry explosion has forced the FDA to not only publish general industry standards in 1993 (finalized in 1997), but to update those standards with more comprehensive rules that are currently being reviewed. Needless to say, lack of adequate funding has proven problematic for the cash-strapped agency in terms of enforcing any regulations the agency hopes to promulgate. en
dc.language.iso en_US en
dash.license LAA en_US
dc.subject Food and Drug Law en
dc.subject human en
dc.subject tissue en
dc.subject industry en
dc.subject banking en
dc.subject oversight en
dc.subject regulation en
dc.title FDA Oversight of the Tissue Bank Industry en
dc.type Paper (for course/seminar/workshop) en_US
dc.date.available 2012-06-07T20:45:45Z

Files in this item

Files Size Format View
tissue_donation_paper_final_with_abstract.pdf 208.0Kb PDF View/Open
tissue_donation_paper_final_with_abstract.rtf 93.83Kb RTF file View/Open
tissue_donation_paper_final_with_abstract.html 74.60Kb HTML View/Open

This item appears in the following Collection(s)

Show simple item record

 
 

Search DASH


Advanced Search
 
 

Submitters